1. Clinical toxicities encountered with paclitaxel (Taxol);Rowinsky;Semin Oncol,1993
2. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin;Choi;Eur J Pharm Biopharm,2004
3. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat;van Hoesel;Cancer Res,1984
4. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice;Gabizon;Cancer Res,1982
5. Medical applications of liposomes;Lasic,1998